• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

人类蛋白质组的分数扩散可作为 SARS-CoV-2 多器官损伤的替代方案。

Fractional diffusion on the human proteome as an alternative to the multi-organ damage of SARS-CoV-2.

机构信息

Instituto Universitario de Matemáticas y Aplicaciones, Universidad de Zaragoza, 50009 Zaragoza, Spain and ARAID Foundation, Government of Aragón, 50018 Zaragoza, Spain.

出版信息

Chaos. 2020 Aug;30(8):081104. doi: 10.1063/5.0015626.

DOI:10.1063/5.0015626
PMID:32872802
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC7585451/
Abstract

The coronavirus 2019 (COVID-19) respiratory disease is caused by the novel coronavirus SARS-CoV-2 (severe acute respiratory syndrome coronavirus 2), which uses the enzyme ACE2 to enter human cells. This disease is characterized by important damage at a multi-organ level, partially due to the abundant expression of ACE2 in practically all human tissues. However, not every organ in which ACE2 is abundant is affected by SARS-CoV-2, which suggests the existence of other multi-organ routes for transmitting the perturbations produced by the virus. We consider here diffusive processes through the protein-protein interaction (PPI) network of proteins targeted by SARS-CoV-2 as an alternative route. We found a subdiffusive regime that allows the propagation of virus perturbations through the PPI network at a significant rate. By following the main subdiffusive routes across the PPI network, we identify proteins mainly expressed in the heart, cerebral cortex, thymus, testis, lymph node, kidney, among others of the organs reported to be affected by COVID-19.

摘要

2019 年冠状病毒(COVID-19)呼吸道疾病是由新型冠状病毒 SARS-CoV-2(严重急性呼吸系统综合症冠状病毒 2)引起的,该病毒使用酶 ACE2 进入人体细胞。这种疾病的特点是在多器官水平上有重要的损伤,部分原因是 ACE2 在几乎所有人体组织中都大量表达。然而,并非所有 ACE2 丰富的器官都受到 SARS-CoV-2 的影响,这表明存在其他多器官途径来传播病毒产生的干扰。我们在这里考虑通过 SARS-CoV-2 靶向的蛋白质的蛋白质-蛋白质相互作用(PPI)网络的扩散过程作为一种替代途径。我们发现了一个亚扩散状态,允许病毒干扰通过 PPI 网络以显著的速率传播。通过沿着 PPI 网络的主要亚扩散路径,我们鉴定出主要在心脏、大脑皮层、胸腺、睾丸、淋巴结、肾脏等被报道受 COVID-19 影响的器官中表达的蛋白质。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/319a/7585451/a5e78a8468bf/CHAOEH-000030-081104_1-g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/319a/7585451/b2a38321f768/CHAOEH-000030-081104_1-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/319a/7585451/a9a5d67330d0/CHAOEH-000030-081104_1-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/319a/7585451/1acb71f4d16a/CHAOEH-000030-081104_1-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/319a/7585451/1f92477b3a80/CHAOEH-000030-081104_1-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/319a/7585451/5c4523f4ab3f/CHAOEH-000030-081104_1-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/319a/7585451/a5e78a8468bf/CHAOEH-000030-081104_1-g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/319a/7585451/b2a38321f768/CHAOEH-000030-081104_1-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/319a/7585451/a9a5d67330d0/CHAOEH-000030-081104_1-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/319a/7585451/1acb71f4d16a/CHAOEH-000030-081104_1-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/319a/7585451/1f92477b3a80/CHAOEH-000030-081104_1-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/319a/7585451/5c4523f4ab3f/CHAOEH-000030-081104_1-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/319a/7585451/a5e78a8468bf/CHAOEH-000030-081104_1-g006.jpg

相似文献

1
Fractional diffusion on the human proteome as an alternative to the multi-organ damage of SARS-CoV-2.人类蛋白质组的分数扩散可作为 SARS-CoV-2 多器官损伤的替代方案。
Chaos. 2020 Aug;30(8):081104. doi: 10.1063/5.0015626.
2
Angiotensin-converting enzyme 2 (ACE2), SARS-CoV-2 and the pathophysiology of coronavirus disease 2019 (COVID-19).血管紧张素转化酶 2(ACE2)、严重急性呼吸综合征冠状病毒 2(SARS-CoV-2)与 2019 冠状病毒病(COVID-19)的病理生理学。
J Pathol. 2020 Jul;251(3):228-248. doi: 10.1002/path.5471. Epub 2020 Jun 10.
3
Matrix metallopeptidase 9 as a host protein target of chloroquine and melatonin for immunoregulation in COVID-19: A network-based meta-analysis.基质金属蛋白酶 9 作为氯喹和褪黑素在 COVID-19 中免疫调节的宿主蛋白靶标:基于网络的荟萃分析。
Life Sci. 2020 Sep 15;257:118096. doi: 10.1016/j.lfs.2020.118096. Epub 2020 Jul 15.
4
What would Sérgio Ferreira say to your physician in this war against COVID-19: How about kallikrein/kinin system?在与 COVID-19 的这场战斗中,塞尔吉奥·费雷拉会对你的医生说些什么:激肽释放酶/激肽系统如何?
Med Hypotheses. 2020 Oct;143:109886. doi: 10.1016/j.mehy.2020.109886. Epub 2020 May 30.
5
Single-cell analysis of SARS-CoV-2 receptor ACE2 and spike protein priming expression of proteases in the human heart.单细胞分析 SARS-CoV-2 受体 ACE2 和刺突蛋白在人心脏中对蛋白酶的预激活表达。
Cardiovasc Res. 2020 Aug 1;116(10):1733-1741. doi: 10.1093/cvr/cvaa191.
6
Computing the Effects of SARS-CoV-2 on Respiration Regulatory Mechanisms in COVID-19.计算 SARS-CoV-2 对 COVID-19 中呼吸调节机制的影响。
ACS Chem Neurosci. 2020 Aug 19;11(16):2416-2421. doi: 10.1021/acschemneuro.0c00349. Epub 2020 Aug 11.
7
Angiotensin-converting enzyme 2: The old door for new severe acute respiratory syndrome coronavirus 2 infection.血管紧张素转化酶 2:新型严重急性呼吸综合征冠状病毒 2 感染的旧门。
Rev Med Virol. 2020 Sep;30(5):e2122. doi: 10.1002/rmv.2122. Epub 2020 Jun 30.
8
ACE2 (Angiotensin-Converting Enzyme 2) in Cardiopulmonary Diseases: Ramifications for the Control of SARS-CoV-2.心肺疾病中的 ACE2(血管紧张素转换酶 2):对 SARS-CoV-2 控制的影响。
Hypertension. 2020 Sep;76(3):651-661. doi: 10.1161/HYPERTENSIONAHA.120.15595. Epub 2020 Aug 12.
9
SARS-CoV-2 and the cardiovascular system.严重急性呼吸综合征冠状病毒 2 型与心血管系统。
Clin Chim Acta. 2020 Nov;510:311-316. doi: 10.1016/j.cca.2020.07.019. Epub 2020 Jul 16.
10
Recombinant human ACE2: potential therapeutics of SARS-CoV-2 infection and its complication.重组人血管紧张素转换酶2:新型冠状病毒感染及其并发症的潜在治疗方法
Acta Pharmacol Sin. 2020 Sep;41(9):1255-1257. doi: 10.1038/s41401-020-0430-6. Epub 2020 Jun 24.

引用本文的文献

1
Monoclonal neutralizing antibodies against SARS-COV-2 S protein.针对严重急性呼吸综合征冠状病毒2(SARS-CoV-2)刺突蛋白的单克隆中和抗体
Am J Transl Res. 2024 Feb 15;16(2):681-689. doi: 10.62347/ALXM8429. eCollection 2024.
2
Molecular Analysis of SARS-CoV-2 Spike Protein-Induced Endothelial Cell Permeability and vWF Secretion.SARS-CoV-2 刺突蛋白诱导的血管内皮细胞通透性和 vWF 分泌的分子分析。
Int J Mol Sci. 2023 Mar 16;24(6):5664. doi: 10.3390/ijms24065664.
3
Detection of COVID-19 from chest x-ray images using transfer learning.利用迁移学习从胸部X光图像中检测新型冠状病毒肺炎

本文引用的文献

1
Post-mortem tissue proteomics reveals the pathogenesis of multi-organ injuries of COVID-19.尸检组织蛋白质组学揭示了新冠病毒病多器官损伤的发病机制。
Natl Sci Rev. 2021 Aug 10;8(11):nwab143. doi: 10.1093/nsr/nwab143. eCollection 2021 Nov.
2
Network medicine framework for identifying drug-repurposing opportunities for COVID-19.用于识别新冠病毒药物再利用机会的网络医学框架。
Proc Natl Acad Sci U S A. 2021 May 11;118(19). doi: 10.1073/pnas.2025581118.
3
ACE2 Expression in Kidney and Testis May Cause Kidney and Testis Infection in COVID-19 Patients.
J Med Imaging (Bellingham). 2021 Jan;8(Suppl 1):017503. doi: 10.1117/1.JMI.8.S1.017503. Epub 2021 Aug 23.
4
Cascading from SARS-CoV-2 to Parkinson's Disease through Protein-Protein Interactions.通过蛋白质-蛋白质相互作用从严重急性呼吸综合征冠状病毒2型关联到帕金森病
Viruses. 2021 May 12;13(5):897. doi: 10.3390/v13050897.
5
Protein-driven mechanism of multiorgan damage in COVID-19.新冠病毒感染中多器官损伤的蛋白质驱动机制
Med Drug Discov. 2020 Oct 20:100069. doi: 10.1016/j.medidd.2020.100069.
血管紧张素转换酶2(ACE2)在肾脏和睾丸中的表达可能导致COVID-19患者的肾脏和睾丸感染。
Front Med (Lausanne). 2021 Jan 13;7:563893. doi: 10.3389/fmed.2020.563893. eCollection 2020.
4
Single-Cell RNA Expression Profiling of ACE2, the Receptor of SARS-CoV-2.新型冠状病毒(SARS-CoV-2)受体ACE2的单细胞RNA表达谱分析
Am J Respir Crit Care Med. 2020 Sep 1;202(5):756-759. doi: 10.1164/rccm.202001-0179LE.
5
COVID-19 and Multiorgan Response.新型冠状病毒肺炎与多器官反应
Curr Probl Cardiol. 2020 Aug;45(8):100618. doi: 10.1016/j.cpcardiol.2020.100618. Epub 2020 Apr 28.
6
A Case of Coronavirus Disease 2019 With Concomitant Acute Cerebral Infarction and Deep Vein Thrombosis.一例2019冠状病毒病合并急性脑梗死和深静脉血栓形成病例
Front Neurol. 2020 Apr 22;11:296. doi: 10.3389/fneur.2020.00296. eCollection 2020.
7
COVID-19, Angiotensin Receptor Blockers, and the Brain.新型冠状病毒肺炎、血管紧张素受体阻滞剂与大脑
Cell Mol Neurobiol. 2020 Jul;40(5):667-674. doi: 10.1007/s10571-020-00861-y. Epub 2020 May 8.
8
SARS-CoV-2 and the testis: similarity with other viruses and routes of infection.SARS-CoV-2 与睾丸:与其他病毒的相似性及感染途径。
Reprod Biomed Online. 2020 Jun;40(6):763-764. doi: 10.1016/j.rbmo.2020.04.009. Epub 2020 Apr 17.
9
A SARS-CoV-2 protein interaction map reveals targets for drug repurposing.一种 SARS-CoV-2 蛋白相互作用图谱揭示了药物再利用的靶标。
Nature. 2020 Jul;583(7816):459-468. doi: 10.1038/s41586-020-2286-9. Epub 2020 Apr 30.
10
COVID-19, hypothalamo-pituitary-adrenal axis and clinical implications.新型冠状病毒肺炎、下丘脑-垂体-肾上腺轴及临床意义
Endocrine. 2020 May;68(2):251-252. doi: 10.1007/s12020-020-02325-1. Epub 2020 Apr 28.